Industry and Business Archives - Oncology Central Oncology Central

i
i

28 Oct 2019 Hematologic
Gilteritinib approved in the EU for relapsed or refractory AML patients with a FLT3 mutation
21 Oct 2019 News
International alliance, driven by Cancer Research UK, targets the detection of cancer at its earliest stage
8 Aug 2019 Lung
Pembrolizumab receives the green light from NICE for NSCLC subtype
26 Jul 2019 Gynecologic
Olaparib made available on the NHS for BRCA-positive ovarian cancer patients
17 Jul 2019 News
Zejula® significantly improves progression-free survival in ovarian cancer patients
10 Jul 2019 Videos
Enhancing the efficacy of clinical trials with Jeffery Edenfield
18 Jun 2019 News
Study investigates why cancer drug prices are rising
23 May 2019 Opinion
ASCO 2019: what should you look out for?
25 Apr 2019 Opinion
Enhancing and improving CAR-T cell therapy: an interview with Bruce Levine
25 Apr 2019 News
One in 10 cancer patients denied drugs recommended by their doctor, study finds
24 Apr 2019 Renal
Keytruda® in combination with Inlyta® receives US FDA approval for renal cell carcinoma
16 Apr 2019 News
Oncology conferences and event highlights: April–June 2019